US Patent Issued to Gilead Sciences on May 13 for "Nucleic acids encoding, and methods of producing, antibodies that bind human chemokine (C-C motif) receptor 8 (CCR8)" (Massachusetts, California Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,282, issued on May 13, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Nucleic acids encoding, and methods of producing, antibodies that bind human chemokine (C-C motif) receptor 8 (CCR8)" was invented by Lara Lewis McGrath (Arlington, Mass.), Fabien Depis (Brookline, Mass.), Changyun Hu (Belmont, Mass.), Leonard G. Presta (San Francisco) and Joshua Adam Bugge (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are various embodiments relating to antibodies and fusion proteins and uses thereof. Some of the embodiments include antibodies that bind CCR8. Some of the embodiments include fusion proteins that bin...